Codexis (CDXS) Liabilities and Shareholders Equity (2010 - 2026)

Codexis (CDXS) recorded quarterly Liabilities and Shareholders Equity of $129.4 million in Q1 2026, down 12.47% quarter-over-quarter from $147.8 million in Q4 2025, and little changed on a YoY basis from $128.9 million in Q1 2025.

Codexis (CDXS) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

Codexis' Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $129.4 million for Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity changed 0.37% year-over-year to $129.4 million; the TTM figure through Mar 2026 stood at $539.4 million (down 3.35% YoY), while the FY2025 annual figure was $147.8 million, down 0.81% from the prior year.
  • Liabilities and Shareholders Equity was $129.4 million for Q1 2026 at Codexis, down from $147.8 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $250.4 million in Q4 2022 to a low of $124.0 million in Q3 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $171.7 million across 5 years, with a median of $149.0 million in 2024.
  • The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity gained 10.89% in 2022, then tumbled 45.46% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $250.4 million in 2022, then sank by 45.46% to $136.6 million in 2023, then grew by 9.12% to $149.0 million in 2024, then retreated by 0.81% to $147.8 million in 2025, then slipped by 12.47% to $129.4 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $129.4 million (Q1 2026), $147.8 million (Q4 2025), and $124.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - 37.37 Mn
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - 811.27 Mn
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - 14.93 Mn
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 1.73 Bn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - 33.89 Mn
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - 23.64 Mn
7 Psyence Biomedical 238.34 Bn 238.33 Bn - 12.81 Mn
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 26.48 Bn
9 Abivax 95.45 Bn 95.45 Bn - 640.56 Mn
10 Codexis 226.01 Mn 160.87 Mn 13.18 Mn 129.37 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 129.37 Mn
Dec 31, 2025 147.80 Mn
Sep 30, 2025 123.96 Mn
Jun 30, 2025 138.25 Mn
Mar 31, 2025 128.89 Mn
Dec 31, 2024 149.01 Mn
Sep 30, 2024 148.18 Mn
Jun 30, 2024 132.01 Mn
Mar 31, 2024 149.56 Mn
Dec 31, 2023 136.56 Mn
Sep 30, 2023 154.46 Mn
Jun 30, 2023 206.76 Mn
Mar 31, 2023 218.07 Mn
Dec 31, 2022 250.39 Mn
Sep 30, 2022 235.29 Mn
Jun 30, 2022 234.97 Mn
Mar 31, 2022 235.27 Mn
Dec 31, 2021 246.38 Mn
Sep 30, 2021 227.55 Mn
Jun 30, 2021 212.31 Mn